Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
LifeVantage Corp (LFVN)
NASDAQ:LFVN
Holding LFVN?
Track your performance easily
Earnings Data
Report Date
Feb 04, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
$0.14Last Year’s EPS
$0.1Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Oct 29, 2024
|% Change Since: 34.12%
|Next Earnings Date:Feb 04, 2025
Earnings Call Sentiment|Positive
The earnings call reflected a strong positive sentiment driven by the successful launch of the MindBody GLP-1 System, significant growth in adjusted EBITDA, and strong demand and sales momentum. However, challenges such as revenue decline, stock outs, and international market difficulties were also highlighted.Company Guidance
During the LifeVantage Q1 2025 earnings call, the company provided several key metrics and insights into their performance and strategic initiatives. LifeVantage reported a first-quarter revenue of $47.2 million, marking an 8.1% decline year-over-year, with foreign currency fluctuations negatively impacting revenue by approximately $200,000. Despite the revenue drop, the company showcased strong profitability metrics, with an adjusted EBITDA increase of 11% year-over-year, reaching $4.4 million and constituting 9.4% of revenue. The gross margin stood at 79.9%, slightly below the previous year's 80.2%. The newly launched MindBody GLP-1 System generated significant excitement, contributing to October being the highest bookings month in the company's history, with enrollments approximately four times the recent monthly averages. The company remains optimistic about its fiscal 2025 outlook, anticipating full-year revenue in the range of $200 million to $210 million and adjusted non-GAAP EBITDA between $18 million and $21 million.Launch of MindBody GLP-1 System
LifeVantage launched the MindBody GLP-1 System, expanding the total addressable market with overwhelming initial response from consultants and customers.
Strong Adjusted EBITDA Growth
Adjusted EBITDA increased by 11% compared to last year, with a margin improvement of 160 basis points.
Successful Clinical Trial Results
The MindBody GLP-1 System showed a 140% average increase in GLP-1 levels, with significant weight loss and fat reduction in a 12-week trial.
High Demand and Sales Momentum
October marked the highest bookings month in company history, with enrollments approximately 4x recent monthly averages.
Cash and No Debt
The company maintains a strong financial position with $14.6 million in cash and no debt.
---
LFVN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
LFVN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 29, 2024 | $12.94 | $12.89 | -0.39% |
| Aug 28, 2024 | $8.75 | $7.72 | -11.77% |
| May 02, 2024 | $6.04 | $6.49 | +7.45% |
| Jan 30, 2024 | $5.73 | $5.22 | -8.90% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does LifeVantage Corp (LFVN) report earnings?
LifeVantage Corp (LFVN) is schdueled to report earning on Feb 04, 2025, TBA Not Confirmed.
What is LifeVantage Corp (LFVN) earnings time?
LifeVantage Corp (LFVN) earnings time is at Feb 04, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is LFVN EPS forecast?
LFVN EPS forecast for the fiscal quarter 2025 (Q2) is $0.14.
---